Tirzepatide
What it is
Tirzepatide is a synthetic 39-amino-acid peptide that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. It belongs to the family of incretin-based peptides and is the active compound marketed under the brand names Mounjaro and Zepbound.
Research context and categorization
Tirzepatide is grouped under the metabolic and weight-regulation category. It is commonly discussed in relation to glucose regulation and body-weight management because of its combined action on two incretin pathways. In clinical study it has been investigated for glycemic control in type 2 diabetes, for chronic weight management, and for obstructive sleep apnea associated with obesity. It is also studied in the context of appetite signaling, gastric emptying, and insulin response. Because tirzepatide carries FDA approval for specific indications, several of these uses are established rather than purely investigational, though any use outside an approved indication remains off-label and should be evaluated by a qualified professional.
Status
- Regulatory status: FDA-approved for specific indications. Mounjaro was approved for type 2 diabetes in 2022, and Zepbound was approved for chronic weight management in 2023 and later for moderate-to-severe obstructive sleep apnea associated with obesity.
- Sport status: Not specifically listed as prohibited on the WADA Prohibited List. As of the 2026 cycle, tirzepatide and related GLP-1 compounds are placed on the WADA Monitoring Program (monitored both in and out of competition) rather than banned, which signals the class is being actively watched and could be reclassified in a future annual review.
Reconstitution notes (general)
Tirzepatide is typically supplied as a lyophilized (freeze-dried) powder that is reconstituted before use. Concentration equals the milligrams in the vial divided by the millilitres of bacteriostatic water added. For example, a 10 mg vial reconstituted with 1 mL of bacteriostatic water yields a 10 mg/mL solution. To work out volumes for a given vial size and target concentration, use the calculator at /pages/tools.
Dilution and handling notes (compound-specific)
Tirzepatide is a reconstituted lyophilized powder, so it does require mixing before use. Bacteriostatic water (sterile water with roughly 0.9 percent benzyl alcohol) is the standard solvent because the benzyl alcohol suppresses microbial growth and extends the usable window; plain sterile water, saline, and tap water are generally avoided for that reason. Common practice targets a working concentration around 10 mg/mL, which keeps measured volumes convenient on a standard U-100 syringe, while 5 mg/mL is also used for larger vials to make small measurements easier to read. Because tirzepatide carries a fatty-acid (long-chain diacid) side-chain modification, it can take slightly longer to go into solution than shorter unmodified peptides, and it generally clears within a few minutes of gentle rolling rather than dissolving instantly. Standard practice is to run the water slowly down the inner wall of the vial rather than adding it forcefully onto the powder, then to swirl or let it rest to dissolve rather than shaking, since aggressive agitation can foam the solution and stress the peptide chain. A properly mixed vial should be clear and colorless with no visible particles. If the powder does not fully clear, brief resting at room temperature usually completes dissolution; a solution that stays cloudy, turbid, or discolored, or that shows particles after mixing, points to degradation, a pH or temperature problem, or contamination rather than normal behavior, and the practical response is to discard that vial. Tirzepatide is also light-sensitive, so vials are kept shielded from strong light, and freeze-thaw cycling degrades the peptide and reduces batch consistency, so the reconstituted vial should not be frozen.
Handling and storage
Store the reconstituted solution refrigerated at 2 to 8 degrees Celsius, kept out of direct light. Wipe the vial stopper with an alcohol swab before drawing, and label the vial with the mix date. A refrigerated reconstituted solution is generally treated as usable for roughly a 4-week window. Discard the vial if the contents become cloudy or discolored or show floating particles.
Related reading
Tools and supplies
- Reconstitution & blend calculators
- Bacteriostatic Water 30 ml
- Gansulin Metal Reusable Pen
- 3 ml Glass Cartridges (10-pack)
- Complete Starter Kit
For laboratory and research reference only. Educational content, not medical, dosing, injection, or therapeutic guidance, and not intended for human or animal use. Any research uses described are investigational and not confirmed or approved benefits. Confirm anything involving health with a licensed professional. References linked above.